top of page

Author: 

Editor(s):

Updated:

ULY CLINIC

ULY CLINIC

17 Septemba 2025, 12:19:19

Generalized tonic-clonic seizures

Generalized tonic-clonic seizures
Generalized tonic-clonic seizures
Generalized tonic-clonic seizures

Generalized tonic-clonic seizures (formerly called grand mal seizures) involve paroxysmal, uncontrolled neuronal discharge affecting the entire brain, causing loss of consciousness, tonic stiffening, and clonic jerking.

They may begin with or without an aura and usually last 2–5 minutes, followed by a postictal phase of confusion, fatigue, and muscle soreness. Complications include status epilepticus, respiratory arrest, trauma, Todd’s paralysis, and rarely, cardiac arrest.


Pathophysiology

  • Diffuse cerebral hyperactivity extending from an initial focus to the whole brain

  • Tonic phase: 10–20 seconds of generalized muscle contraction

  • Clonic phase: ≈60 seconds of rhythmic jerking and hyperventilation

  • Airway compromise may occur due to secretions, apnea, and tongue biting

  • Postictal phase includes confusion, headache, fatigue, amnesia, and muscle soreness


What happens During a Generalized Tonic-Clonic Seizure

Phase

Key Features

Before the seizure

Prodrome: myoclonic jerks, headache, mood changes, aura (flashing lights, odors)

Tonic phase

Loss of consciousness, stiffening of muscles, arms flexed, legs extended, back arching, apnea, cyanosis, profuse salivation, diaphoresis, dilated pupils

Clonic phase

Bilateral rhythmic jerking, facial grimacing, tongue biting, foamy saliva, gradually decreasing intensity

Postictal phase

Gradual cessation of movements, unresponsiveness, urinary incontinence, confusion, drowsiness, amnesia, headache, muscle soreness


History and Physical Examination

History:
  • If not witnessed, obtain a description from a companion

  • Ask about prodromal symptoms, aura, seizure onset, spread, duration

  • Inquire about previous seizures, family history, drug therapy compliance, stress, or sleep deprivation


Physical Examination:
  • Check for injury, focal neurologic signs, and LOC changes

  • Examine arms, legs, and face (including tongue) for trauma or residual weakness

  • Monitor vital signs and neurologic status during postictal recovery


Safety Consideration:
  • Ensure a safe environment; never restrain or force objects into the mouth

  • Turn the patient to one side to prevent aspiration

  • Observe and record seizure activity and intervals


Medical causes

Cause

Key Features

Brain abscess

Seizures during acute or post-abscess stages, increased ICP, focal deficits, headache, nausea, vomiting

Brain tumor

Seizures may be first sign, progressive LOC decrease, morning headache, focal deficits, papilledema

Chronic renal failure

Twitching, myoclonic jerks, fatigue, peripheral neuropathy, skin changes, uremic symptoms

Eclampsia

Frontal headache, visual disturbances, high BP, peripheral edema, fever, oliguria

Encephalitis

Fever, headache, photophobia, nuchal rigidity, cranial nerve palsies, myoclonic jerks

Epilepsy (idiopathic)

Unknown cause, recurrent seizures

Head trauma

Immediate or delayed seizures, focal deficits, increased ICP, soft tissue injury, altered LOC

Hepatic encephalopathy

Fetor hepaticus, asterixis, hyperactive DTRs, late generalized seizures

Hypoglycemia

Trembling, blurred vision, myoclonic jerks, diaphoresis, decreased LOC

Hyponatremia

Seizures when Na⁺ <125 mEq/L, fatigue, confusion, hypotension, muscle weakness

Hypoparathyroidism

Neuromuscular irritability, hyperactive DTRs, tetany

Hypoxic encephalopathy

Myoclonic jerks, coma; later dementia, visual agnosia, ataxia

Neurofibromatosis

Brain lesions, café-au-lait spots, seizures, ataxia, monocular blindness

Stroke

Seizures (focal>generalized), hemiplegia, aphasia, sensory deficits, memory loss

Arsenic poisoning

Generalized seizures, garlicky breath, GI symptoms, neuropathy, skin changes

Barbiturate withdrawal

Seizures 2–4 days after last dose; status epilepticus possible

Drugs/Toxins

High levels of theophylline, lidocaine, meperidine, penicillin, cimetidine, phenothiazines, TCAs, amphetamines, isoniazid, vincristine


Emergency interventions

  • Assess airway, breathing, circulation

  • Protect the patient: towel under head, remove sharp objects, loosen clothing

  • Turn patient on side to prevent aspiration

  • Do not restrain or force objects into mouth

  • If seizure >4 minutes or recurrent: suspect status epilepticus

    • Establish airway, IV line, oxygen, cardiac monitoring

    • Administer diazepam or lorazepam IV in 10–20 min intervals

    • Correct hypoglycemia with dextrose + thiamine

  • Prepare for intubation, suction, NG tube if needed

  • Record observations and intervals carefully


Special considerations

  • Monitor for recurring seizures postictally

  • Prepare for EEG, CT, MRI

  • Offer emotional support to patient and family


Patient counseling

  • Teach family how to observe and record seizure activity

  • Emphasize medication adherence and follow-up

  • Discuss possible adverse effects of drugs

  • Advise patient to carry medical identification


Pediatric pointers

  • Generalized seizures are common in children; 75–90% of epileptics have first seizure before age 20

  • Febrile seizures in ages 3 months–3 years may predispose to later epilepsy

  • Other pediatric causes: metabolic disorders, perinatal injury, infections, Reye’s syndrome, Sturge-Weber syndrome, AV malformation, lead poisoning, idiopathic

  • Rarely, DPT vaccine pertussis component may trigger seizures


References
  1. Berkowitz CD. Berkowitz’s Pediatrics: A Primary Care Approach. 4th ed. USA: American Academy of Pediatrics; 2012.

  2. Buttaro TM, Tybulski J, Bailey PP, Sandberg-Cook J. Primary Care: A Collaborative Practice. St. Louis, MO: Mosby Elsevier; 2008.

  3. Lehne RA. Pharmacology for Nursing Care. 7th ed. St. Louis, MO: Saunders Elsevier; 2010.

  4. McCance KL, Huether SE, Brashers VL, Rote NS. Pathophysiology: The Biologic Basis for Disease in Adults and Children. Maryland Heights, MO: Mosby Elsevier; 2010.

  5. Sommers MS, Brunner LS. Pocket Diseases. Philadelphia, PA: F.A. Davis; 2012.

bottom of page